Fibroin-like Protein Production via Dynamic Glucose Control

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

The production of fibroin-like proteins in Escherichia coli is hindered by the accumulation of organic acids, such as acetic acid, which reduces cell growth and protein expression efficiency.

Innovation Solution

A method involving the culture of Escherichia coli with a gene encoding the fibroin-like protein, where the expression is induced while limiting the carbon source, specifically glucose, to maintain acetic acid levels at 4.5 g/L or less, thereby reducing organic acid accumulation and enhancing protein production.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If glucose uptake rate is increased to enhance protein production, then productivity improves, but organic acid accumulation increases which reduces cell growth and expression efficiency

Engineering Contradiction:
Improveprotein production rateVSAvoidorganic acid accumulation
Core Design Contradiction:
ProductivityVSObject-affected harmful factors

Solution Approach 1:

The patent implements dynamic control of glucose uptake rate throughout the fermentation process. The glucose uptake rate is adjusted at different stages: initially set at 0.8-1.2 g/g/h for cell growth, then reduced to 0.2-0.6 g/g/h during protein expression phase. This dynamic adjustment prevents organic acid accumulation while maintaining high productivity, resolving the contradiction between production rate and harmful acid buildup.

Inventive Principle:
Principle #15Dynamics

Solution Approach 2:

The patent employs periodic feeding strategies where glucose is supplied in controlled intervals rather than continuously. The feeding rate is modulated based on cell density and metabolic state, creating periodic cycles of nutrient supply that allow cells to process glucose efficiently without overwhelming the metabolic pathways, thereby preventing acetate accumulation while sustaining production.

Inventive Principle:
Principle #19Periodic action

2Reliability

If acetic acid concentration is maintained at low levels to improve cell growth, then cell viability increases, but glucose uptake rate must be limited which reduces protein expression efficiency

Engineering Contradiction:
Improvecell growthVSAvoidprotein expression amount
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

The patent performs preliminary cell growth phase where cells are cultivated under optimized conditions to reach high cell density before inducing protein expression. During this preliminary phase, glucose is supplied at rates that maximize cell growth while keeping acetate below inhibitory levels. This preliminary action builds a robust cell population that can then undergo high-level expression without suffering from acid accumulation issues.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent dynamically shifts glucose uptake rate from growth-optimized levels (0.8-1.2 g/g/h) to expression-optimized levels (0.2-0.6 g/g/h) after cell density reaches a threshold. This dynamic transition allows the system to first ensure reliable cell growth with low acetate, then maintain that reliability while achieving high protein expression through controlled metabolic flux.

Inventive Principle:
Principle #15Dynamics

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach improves the accumulation and productivity of fibroin-like proteins by minimizing organic acid buildup, leading to increased specific production rates and cumulative productivity.

Implementation Method 1

when Escherichia coli is cultured, acetic acid accumulation can be reduced by reducing the glucose uptake rate

Methodology Applied
Scientific EffectFermentation: Fermentation

Data Source

PatentUS9926348B2Method for producing fibroin-like protein
Publication Date: 2018.03.27 CRANE INC
  • US9926348B2 patent drawing
  • US9926348B2 patent drawing
  • US9926348B2 patent drawing

AI summary

A method for producing a fibroin-like protein is described. A fibroin-like protein is produced by culturing Escherichia coli having a gene encoding the fibroin-like protein in a medium, inducing expression of the gene encoding the fibroin-like protein, and collecting the fibroin-like protein, wherein the accumulation of an organic acid at the time of inducing the expression is reduced.